Literature DB >> 12780904

The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin.

H R Frydoonfar1, D R McGrath, A D Spigelman.   

Abstract

OBJECTIVE: Naringenin, a naturally occurring flavonoid found in citrus fruits, is known to have anticarcinogenic properties. We have examined the effect of Naringenin on cell proliferation of an HT-29 colon cancer cell line.
METHODS: HT-29 colon cancer cells were cultured in 96-well tissue culture plates. Naringenin concentrations ranging from 0.02 to 2.85 mmol were added to the wells of the Test group. The Control group contained all the elements present in the Test group with the exception of Naringenin. Cell proliferation was measured by colourimetric assay using the 2% WST-1 cell proliferation kit.
RESULTS: Significant inhibition of cell proliferation was observed in HT29 colon cancer cells exposed to Naringenin at doses greater than 0.71 mmol.
CONCLUSIONS: These results suggest a potential role for citrus fruits as a source of chemoprotective agents for colon cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780904     DOI: 10.1046/j.1463-1318.2003.00444.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  18 in total

Review 1.  Role of pomegranate and citrus fruit juices in colon cancer prevention.

Authors:  Saravana Kumar Jaganathan; Muthu Vignesh Vellayappan; Gayathri Narasimhan; Eko Supriyanto
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

2.  Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats.

Authors:  Tety Leonardi; Jairam Vanamala; Stella S Taddeo; Laurie A Davidson; Mary E Murphy; Bhimanagouda S Patil; Naisyin Wang; Raymond J Carroll; Robert S Chapkin; Joanne R Lupton; Nancy D Turner
Journal:  Exp Biol Med (Maywood)       Date:  2010-06

3.  Sulfation of dietary flavonoids by human sulfotransferases.

Authors:  C Huang; Y Chen; T Zhou; G Chen
Journal:  Xenobiotica       Date:  2009-04       Impact factor: 1.908

4.  Improved oxidation of naringenin to carthamidin and isocarthamidin by Rhodotorula marina.

Authors:  Anna Madej; Jarosław Popłoński; Ewa Huszcza
Journal:  Appl Biochem Biotechnol       Date:  2014-03-11       Impact factor: 3.094

5.  Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer.

Authors:  Mohamed Salah I Abaza; Khaled Y Orabi; Ebtehal Al-Quattan; Raja'a J Al-Attiyah
Journal:  Cancer Cell Int       Date:  2015-04-24       Impact factor: 5.722

6.  Assessment of total phenolic and flavonoid content, antioxidant properties, and yield of aeroponically and conventionally grown leafy vegetables and fruit crops: a comparative study.

Authors:  Suman Chandra; Shabana Khan; Bharathi Avula; Hemant Lata; Min Hye Yang; Mahmoud A Elsohly; Ikhlas A Khan
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-23       Impact factor: 2.629

7.  Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats.

Authors:  Shiuan-Pey Lin; Yu-Chi Hou; Shang-Yuan Tsai; Meng-Ju Wang; Pei-Dawn Lee Chao
Journal:  Biomedicine (Taipei)       Date:  2014-08-13

8.  Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest.

Authors:  Md Sultan Ahamad; Sahabjada Siddiqui; Asif Jafri; Sheeba Ahmad; Mohammad Afzal; Md Arshad
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 9.  Cytotoxicity of dietary flavonoids on different human cancer types.

Authors:  Katrin Sak
Journal:  Pharmacogn Rev       Date:  2014-07

10.  Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model.

Authors:  Fon-Chang Liu; Chun-Hsu Pan; Ming-Tsung Lai; Shu-Jen Chang; Jing-Gung Chung; Chieh-Hsi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.